Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fusion Antibodies Plc | FAB | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.10 | -2.35% | 4.15 | 10:43:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.25 | 4.15 | 4.25 | 4.25 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 01/10/2024 09:51 by gtc1508 hxxps://x.com/fsnantNew investor video from FAB |
Posted at 26/9/2024 09:59 by troutisout AGM in just over a week's time and I am hoping we see a trading update for H1, FAB have been very good with the IR/PR recently including Investor Meet and Shard Investor evening, the mood portrayed by AK has been very positive and the Broker note, shows good forecasts for growth in revenues and as traction for their new platforms grows this will only get better. A good little Company thriving once more and more people will start to notice it and jump aboard. |
Posted at 25/9/2024 08:43 by thiopia Given the benchmark valuation for this type of Company is now $500m+ I think FAB don't need to ever consider a retail or even Institutional placing. The right thing to do would be if they consider their are opportunities they wish to pursue outside of current funded business plan is to take on board a strategic cornerstone investor selling a small percentage of the Company at say 10p or 25p or 50pAbcam/Danaher might be an example of a Company who can see the potential of FAB and an early miniscule investment now would give them a seat at the table if any M&A activity kicks off |
Posted at 25/9/2024 06:40 by troutisout bri15,It matters a lot to long term investors the rampers and derampers don't care at the moment, they are looking for a short term profit.... |
Posted at 24/9/2024 19:15 by thiopia This info is very interesting...How did Shard or #FAB come upon this info ? I would not rule out the Investor who made on FairJourney or Investors who lost out on the FairJourney investment bid were casting around for alternatives and made preliminary informal approaches to #FAB ? |
Posted at 24/9/2024 17:26 by reidy66 Not an investor but present at the investor presentation. Seems a good little company. Aiming to be in profit .No fundraise needed at present but never say never .Aim is to get back to where it was .PJ |
Posted at 24/9/2024 13:06 by gtc1508 New technology increasing expression by 30xToday 14:01This was a key message at their latest investor presentation. I’m sure that any big players would snap their arms off to get hold of their tech which can improve their production 30 fold. If FAB can get some royalties from that with existing assets of Pharmas then that could be huge |
Posted at 24/9/2024 08:06 by gtc1508 Definitely the time to buy:- Strong q1 update. - Cash position strong and runway extended by 6 months - new service lines being developed with potential to increase expression 30 fold of clients existing assets - multiple milestone/royalty generating projects - validation with USA national cancer institute going well and being expanded. - revenues growing and slightly ahead of forecast. Operational costs down and continuing to give benefit. - CEO extremely bullish at latest investor meet company and scathing of current valuation. - investor presentation at Shard tonight. Overall the future looks extremely promising for this hidden gem. They’ve overcome the down turn and emerged fitted stronger and better positioned to address massive market with their world leading tech |
Posted at 17/9/2024 07:25 by troutisout So it looks like the Company have a planned PR/IR schedule, the results, followed by the Investor Meet, the Shard Capital Investor evening and then the AGM, which I suspect is just far enough away from the recent Director buys and the end of H1-2025 for a trading update (which I believe will confirm the bullishness of some of the recent statements from the BoD...) |
Posted at 05/9/2024 08:44 by troutisout Looking forward to this next week, "whilst additionally providing an update on the business and current trading"Investor briefing Fusion will host an online live presentation open to all investors on Thursday, 12 September 2024 at 3pm BST, delivered by Dr Adrian Kinkaid, CEO and Stephen Smyth, CFO. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results whilst additionally providing an update on the business and current trading. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
